C

    Cardio Diagnostics Holdings Inc (CDIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.87
    +0.02 (+1.08%)

    Market Cap: $5.47M

    Last updated: Sep 01, 2026 at 7:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    31%(4/13)
    Avg Surprise
    -129.46%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.51N/AN/ABeat+47.4%
    Mar 26
    		$-0.63N/AN/ABeat+35.1%
    Dec 25
    		$-0.80N/AN/ABeat-1906.3%
    Sep 25
    		$-0.98$-0.22-345.45%Miss+45.6%
    Jun 25
    		$-0.97$-0.22-340.91%Miss+46.1%
    Mar 25
    		$-0.97$-0.21-361.90%Miss+83.8%
    Dec 24
    		$-0.04N/A+77.78%Beat+96.2%
    Sep 24
    		$-1.80$-1.50-20.00%Miss+64.6%
    Jun 24
    		$-1.80$-2.70+33.33%Beat+83.2%
    Mar 24
    		$-6.00$-2.40-150.00%Miss-141.0%
    Dec 23
    		$-1.06$-0.14-687.33%Miss-254.3%
    Sep 23
    		$-5.08$-4.80-5.83%Miss-946.7%
    Jun 23
    		$-10.72$-4.80-123.33%Miss-1922.6%
    Mar 23
    		$14.63$-5.40+370.93%Beat+48866.7%
    Dec 22
    		$-0.30$-0.09-233.33%Miss-1400.0%
    Sep 22
    		$0.60N/A+103.03%Beat-
    Jun 22
    		$-0.53N/AN/ABeat-
    Mar 22
    		$-0.03N/AN/ABeat-
    Dec 21
    		$-0.02N/AN/ABeat-
    Sep 21
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.64EV/EBITDA-22.48x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-27950.00%
    ROE-75.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-526.02x
    Current Ratio17.15xQuick Ratio17.15x
    Trading Statistics
    Beta2.22Avg Volume50.90K
    52-Week High$7.9152-Week Low$0.97

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.95
    SMA 20$1.91
    SMA 50$1.86
    SMA 200$2.31
    EMA 10$1.91
    EMA 20$1.89
    EMA 50$1.88
    EMA 200$2.69

    MACD

    Line: 0.03Signal: 0.04Hist: -0.01

    ADX

    ADX: 13.8+DI: 17.1-DI: 16.9

    Aroon & PSAR

    Aroon Up52.0
    Aroon DownN/A
    PSAR$2.24

    Bollinger Bands

    Upper Band$2.20
    Lower Band$1.62
    %B Position3009%(Upper)
    Band Width0.43

    RSI (14-Day)

    Neutral
    49.5

    Momentum Oscillators

    Stoch %K30.5
    Stoch %D37.8
    Williams %R-82.1
    ROC (10d)-6.0%
    Momentum-0.12
    CCI (20d)-30.6
    MFI (14d)64.0

    Volatility Measures

    ATR (14d)$0.17(9.3%)
    StdDev (20d)0.14
    Hist Vol104.6%(High)

    Volume Flow

    VWAP$1.85
    OBV138.0M
    AD Line20.6B
    CMF (20d)-0.068

    Volume Metrics

    Avg Vol (20d)52.2K
    Vol Ratio0.4x(Low)
    VWMA (20d)$2.00

    Pivot Points

    R3$1.99
    R2$1.94
    R1$1.90
    Pivot Point$1.85
    S1$1.81
    S2$1.76
    S3$1.72

    Advanced Oscillators

    TSI5.33
    Ultimate Osc43.1
    KST125.59

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5,360$2,680$3,555$2,855$7,475$940$4,512$6,580$7,870$15,928$5,310$10,030
    Cost of Revenue$0$0$159,310$0$0$0$49,166$0$0$0N/A$0
    Gross Profit$5,360$2,680$3,555$2,855$7,475$940$4,512$6,580$7,870$15,928$5,310$10,030
    Operating Expenses$1.50M$1.79M$1.47M$1.71M$1.69M$1.63M$1.52M$1.42M$1.29M$4.17M$1.55M$1.45M
    R&D$162,929$129,776$0$0$178,536$118,784$0$0$0$10,840$7,492$38,708
    SG&A$1.14M$1.46M$82,902$1.71M$1.30M$1.28M$91,276$1.42M$1.29M$4.12M$1.49M$1.38M
    Operating Income$-1,498,147$-1,784,837$-1,463,222$-1,711,597$-1,678,699$-1,630,560$-1,516,402$-1,408,967$-1,282,460$-4,158,048$-1,541,998$-1,444,191
    Interest Income$119$118$146$189$190$187$221$280$282$281$301$283
    Interest Expense$3,440$3,439$2,292$3,128$4,690$4,691$3,127$3,879$5,817$5,817$-348,600$457,441
    Income Before Tax$-1,501,468$-1,788,158$-1,465,368$-1,714,536$-1,683,199$-1,635,064$-1,519,308$-1,412,566$-1,287,995$-4,163,584$-1,388,929$-1,932,382
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,501,468$-1,788,158$-1,465,368$-1,714,536$-1,683,199$-1,635,064$-1,519,308$-1,412,566$-1,287,995$-4,163,584$-1,388,929$-1,932,382
    EBITDA$-1,406,027$-1,693,506$-1,371,291$-1,624,948$-1,594,056$-1,509,744$-1,434,936$-1,330,049$-1,206,876$-4,135,247$-1,676,013$-1,434,999
    EBIT$-1,501,468$-1,788,158$-1,465,368$-1,714,536$-1,683,199$-1,635,064$-1,519,308$-1,412,566$-1,287,995$-4,163,584$-1,737,830$-1,475,224
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CDIO

    News

    Price to sales forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW

    This article focuses on the "Price to sales forward" metric for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIOW). It appears to be a financial data page from TradingView, displaying the value and change for this specific financial ratio for the company.

    TradingView•8/24/26•
    Neutral

    Cardio Diagnostics begins using investor presentation; highlights commercial tests, CMS payment & CLIA lab

    Cardio Diagnostics (CDIO) is utilizing a new investor presentation to highlight the commercial availability of its Epi+Gen CHD and PrecisionCHD tests, a CMS final payment rate of $854 per test, and the benefits of its in-house CLIA lab operations. The presentation also covers the company's intellectual property, reimbursement progress, and efforts in securing in-network coverage and commercial payer engagement. The in-house lab has reduced initial lab COGS by approximately 30% and improved turn-around time to 7–10 days.

    TradingView•8/20/26•
    Bullish

    Cardio Diagnostics wins federal CLIA license for high-complexity Iowa City lab

    Cardio Diagnostics has received a federal CLIA license for its new high-complexity lab in Iowa City, Iowa, following an inspection with no deficiencies. This enables the company to process tests in-house, replacing third-party services. Management anticipates this move will improve gross margins by approximately 40% at scale due to a more controllable cost structure as test volumes increase.

    Bitget•8/18/26•
    Bullish

    Cardio Diagnostics Holdings Opens In-House High Complexity Clia-Certified Laboratory in Iowa City

    Cardio Diagnostics Holdings has officially launched its CLIA-certified laboratory in Iowa City, Iowa, enabling the company to have end-to-end control over the processing of its multi-omics clinical tests. This new facility replaces a third-party arrangement and was established within a year, receiving its federal CLIA license with no deficiencies. The company has also secured out-of-state licenses and plans to use the facility for pioneering research in precision epigenetic methods for cardiovascular care.

    www.marketscreener.com•8/18/26•
    Bullish

    Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City

    Cardio Diagnostics Holdings, Inc. has officially launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa, enabling end-to-end control over the processing of its multi-omics clinical tests. This move is expected to improve quality control, streamline turnaround times for patient results, increase test margins, and expand research capabilities for precision monitoring of cardiovascular health. The company anticipates achieving gross margins of approximately 40% at scale and aims to further reduce the current 7-10 business day turnaround time for test results.

    Yahoo Finance•8/18/26•
    Bullish

    Frequently Asked Questions About CDIO

    Does CDIO pay dividends?
    Cardio Diagnostics Holdings Inc (CDIO) does not currently pay a regular dividend.
    What is CDIO's market cap?
    Cardio Diagnostics Holdings Inc (CDIO) has a market capitalization of $5.47M with a current stock price of $1.87.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In